Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Emergency Nurse : the Journal of the RCN Accident and Emergency Nursing Association|November 22, 2022
Benefits of a collaborative approach to service evaluation in urgent careCraig Brown, Deborah Armstrong, Alexandra Gibbins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancerThomas C Krivak, Kathleen M Darcy, Chunqiao Tian, et al.Frontiers in Oncology|August 22, 2013
Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group StudyChunqiao Q Tian, Kathleen M Darcy, Thomas C Krivak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancerStephen A Cannistra, Ursula A Matulonis, Richard T Penson, et al.Critical Care Medicine|January 6, 2007
Clinical practice guidelines for support of the family in the patient-centered intensive care unit: American College of Critical Care Medicine Task Force 2004-2005Judy E Davidson, Karen Powers, Kamyar M Hedayat, et al.Neurobiology of Aging|April 9, 2015
Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal womenRichard L Doty, Isabelle Tourbier, Victoria Ng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2020
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO GuidelinePanagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive RelapseIgnace Vergote, Deborah Armstrong, Giovanni Scambia, et al.Cancer|January 31, 2018
Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancerAnya Litvak, Bhavina Batukbhai, Stuart D Russell, et al.Gynecologic Oncology|March 23, 2016
The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumorsJoelle Hillion, Sujayita Roy, Mohammad Heydarian, et al.Pageof 3